Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.64 USD | -0.97% | +2.25% | -0.52% |
17/05 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
17/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.52% | 16TCr | |
+32.09% | 69TCr | |
+29.39% | 58TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer : Mizuho Downgrades Pfizer to Neutral Rating From Buy, Price Target is $42